Summarily, dioscin ameliorates myocardial ischemia/reperfusion injury through suppressing reactive oxygen species via downregulation of Nox2 and upregulation of the antioxidative enzyme, including SOD, CAT, GPx, and GSH, leading to alleviate cardiac dysfunction. The gene discussed is SOD1; the disease is myocardial ischemia.